Memo Therapeutics
ID: 7647719Memo Therapeutics is an antibody Discovery Technology founded in 2012.
7
Funding Rounds
$83.6m
Money raised
Recent Funding Rounds
Overview
Memo Therapeutics is an antibody Discovery Technology founded in 2012.
- Website:
- Business model: B2B
- Headquarters: Zürich
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Memo Therapeutics has raised a total of $83.6m in funding over 7 rounds.
Key Insights:
- Memo Therapeutics November 2023 Series C Funding Round: $28m
- Memo Therapeutics February 2022 Funding Round: $40m
- Memo Therapeutics May 2018 Series A Funding Round: $5.5m
- Memo Therapeutics May 2018 Series A Funding Round: $5.5m
- Memo Therapeutics July 2015 Series A Funding Round: $2.3m
- Memo Therapeutics July 2015 Series A Funding Round: $2.3m
Industries
Memo Therapeutics is active in the following industries: